Skip to main content
Signal8

Faeth Therapeutics, Inc. (FTH)

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Faeth Therapeutics, Inc. logo

Faeth Therapeutics, Inc.

NASDAQ:FTHHealthcare
-15.02%$17.08
AH Close$17.08+0.00%vs close
Mkt Cap$441.35M
Float13.98M
O/S25.84M
Inst Own54.5%
SI14.8%
Dilution
Faeth Therapeutics, Inc. logoNASDAQ:FTH$17.08-15.02%
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$21.09M
Total Assets$22.9M
Free Cash Flow-$20.47M
Debt & Equity
Debt 8%
Equity 92%
Total Debt$1.51M
Total Equity$18.59M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in FTH's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$22.9M
Liabilities$4.31M
Accounts Receivable$0
Accounts Payable$689K
Inventory$0
PP&E (Net)$1.38M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue$0$0$0$0$0$0$0$0
YoY Growth--------
Cost of Revenue$0$551K$571K$1.81M$685K$209K$73K$44K
Gross Profit$0-$551K-$571K-$1.81M-$685K-$209K-$73K-$44K
Gross Margin--------
Research and Development$10.96M$18.63M$18.3M$29.58M$21.66M$11.92M$8.35M$8.23M
Selling, General, and Administrative$11.33M$12.48M$18.77M$17.73M$15.13M$7.53M$4.01M$4.51M
Other$0$0-$571K$0$0-$209K$0$28K
Total Operating Expenses$22.29M$31.11M$36.49M$47.31M$36.8M$19.24M$12.36M$12.74M
Operating Income (EBIT)-$22.29M-$31.66M-$37.06M-$49.12M-$37.48M-$19.45M-$12.44M-$12.74M
Operating Margin--------
Interest Expense$32K$90K$144K$219K$670K$1.69M$2.26M$327K
Interest Income$1.24M$2.55M$3.62M$1.78M$800K$2K$2K$0
Other Income (Expense)$1.2M$1.51M$2.96M$532K$688K-$649K-$4.3M-$299K
Income Before Tax (EBT)-$21.09M-$30.16M-$34.1M-$48.59M-$36.79M-$20.1M-$16.74M-$13.04M
Income Tax Expense$0$0$0$0$0$0$0$0
Net Income-$21.09M-$30.16M-$34.1M-$48.59M-$36.79M-$20.1M-$16.74M-$13.04M
Net Income Margin--------
Supplementary Data
EPS-16.72-24.01-24.40-31.65-26.56-13.21-14.01-11.49
Diluted EPS-16.72-24.01-24.40-31.65-26.56-13.21-14.01-11.49
Weighted Average OS1.26M1.26M1.40M1.54M1.39M1.53M1.47M1.47M
EBITDA-$20.91M-$28.75M-$35.61M-$47.02M-$35.44M-$18.2M-$14.41M-$12.7M
EBITDA Margin--------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Assets
Current Assets
Cash and Cash Equivalents$8.67M$9.99M$13.01M$17.8M$7.16M$16.6M$251K$653K
Short-Term Investments$12.52M$31.34M$52.75M$89.32M$140.46M$0$0$0
Cash and Short-Term Investments$21.18M$41.34M$65.76M$107.12M$147.62M$16.6M$251K$653K
Accounts Receivable$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0
Other Current Assets$92K$120K$325K$344K$374K$2.1M$0$123K
Total Current Assets$21.51M$41.93M$67.25M$108.59M$148.54M$20.08M$502K$1.28M
Long-Term Assets
Property, Plant & Equipment Net$1.38M$3.38M$7.04M$9.72M$4.64M$1.27M$268K$123K
Goodwill$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0
Other Long-Term Assets$18K$48K$86K$63K$39K$86K$447K$447K
Total Long-Term Assets$1.4M$3.43M$7.12M$9.79M$4.68M$1.35M$715K$570K
Other Assets$0$0$0-$1K$0$0$0$0
Total Assets$22.9M$45.36M$74.37M$118.38M$153.22M$21.43M$1.22M$1.85M
Liabilities
Current Liabilities
Accounts Payable$689K$244K$1.69M$4.47M$2.46M$3.88M$3.45M$1.11M
Short-Term Debt$0$0$0$0$0$0$16.05M$696K
Current Income Tax Payable$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$2.08M$652K
Other Current Liabilities$1.4M$2.01M$0$0$0$0-$1.96M$207K
Total Current Liabilities$4.25M$5.45M$5.64M$9.07M$4.89M$4.83M$21.71M$2.66M
Long-Term Liabilities
Long-Term Debt$59K$0$0$0$0$567K$0$4.05M
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$67K$0$149K$52K$48.16M$48.62M
Total Long-Term Liabilities$59K$1.53M$3.84M$5.9M$1.82M$705K$48.16M$52.67M
Other Liabilities$0$0$0$0$0$0$0$0
Total Liabilities$4.31M$6.97M$9.48M$14.97M$6.71M$5.54M$69.88M$55.33M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$72.34M$47.55M$47.55M
Common Stock$0$3K$3K$3K$3K$0$2K$2K
Retained Earnings-$283.14M-$262.05M-$231.9M-$197.79M-$149.21M-$112.41M-$92.31M-$75.57M
Comprehensive Income & Other$1K-$13K-$209K-$1M-$333K$0-$2K-$314K
Other Stockholders' Equity$301.73M$300.44M$296.79M$301.2M$295.72M$128.31M$23.65M$22.09M
Total Equity$18.59M$38.39M$64.89M$103.41M$146.51M$15.89M-$68.66M-$53.48M
Minority Interest$0$0$0$0$0$0$0$0
Total Liabilities and Equity$22.9M$45.36M$74.37M$118.38M$153.22M$21.43M$1.22M$1.85M
Supplementary Data
Total Debt$1.51M$3.85M$6.21M$8.03M$2.35M$685K$16.05M$4.75M
Net Debt-$7.16M-$6.15M-$6.8M-$9.76M-$4.8M-$15.91M$15.8M$4.09M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Operating Activities
Net Income-$21.09M-$30.16M-$34.1M-$48.59M-$36.79M-$20.1M-$16.74M-$13.04M
Depreciation & Amortization$139K$1.32M$1.35M$1.35M$685K$209K$73K$44K
Deferred Income Tax$0$0$0$0$19K$0$0$0
Stock-Based Compensation$1.27M$3.13M$4.45M$5.81M$5.66M$1.49M$0$1.19M
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0
  Accounts Payable$233K-$445K-$2.33M$2.02M-$1.43M$335K$2.34M$931K
  Other Working Capital-$1.82M-$44K-$2M-$1.01M$1.54M-$732K$1.13M$559K
Total Working Capital Change-$1.59M-$489K-$4.33M$1.01M$117K-$397K$3.47M$1.49M
Other Non-Cash Items$811K$1.52M$603K$1.4M$57K$1.09M$4.63M$349K
Net Cash from Operating-$20.45M-$24.67M-$32.02M-$39.03M-$30.26M-$17.7M-$8.57M-$10.31M
Investing Activities
Capital Expenditures-$16K-$146K-$180K-$321K-$2.03M-$1.21M-$53K-$31K
Acquisitions$250K$0$166K$15K$318K-$197K$0$0
Purchases of Investments-$25.16M-$44.59M-$21.15M-$46.87M-$183.67M$0$0$0
Sales of Investments$44.69M$67.18M$59.58M$97.12M$42.26M$0$0$0
Other Investing Activities$0$0$0$0$0$0$0$0
Net Cash from Investing$19.77M$22.44M$38.41M$49.95M-$143.12M-$1.4M-$53K-$31K
Financing Activities
Debt Repaid$648K$811K$761K$629K$255K-$526K-$8.07M-$750K
Common Stock Issuance$7K$34K$48K$342K$140.59M$0$154K$0
Common Stock Repurchases-$1K$0-$10.38M$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0
Other Financing Activities-$3K-$10K-$76K$0$109K-$2.08M$0$0
Net Cash from Financing-$645K-$787K-$11.17M-$287K$163.94M$35.45M$8.22M$750K
Forex Effect$0$0$0$0$0$0$1$0
Net Change in Cash-$1.33M-$3.02M-$4.78M$10.64M-$9.44M$16.34M-$402K-$9.59M
Supplementary Data
Operating Cash Flow-$20.45M-$24.67M-$32.02M-$39.03M-$30.26M-$17.7M-$8.57M-$10.31M
Capital Expenditure-$16K-$146K-$180K-$321K-$2.03M-$1.21M-$53K-$31K
Free Cash Flow-$20.47M-$24.82M-$32.2M-$39.35M-$32.28M-$18.91M-$8.62M-$10.34M
Cash at Beginning$9.99M$13.01M$17.8M$7.16M$16.6M$251K$653K$10.25M
Cash at End$8.67M$9.99M$13.01M$17.8M$7.16M$16.6M$251K$653K